Point-of-Care Potassium and Artificial Intelligence-enabled Electrocardiography for Hyperkalemia Detection

Author(s): Chin Lin, PhD, Chien-Chou Chen, MD, Chin-Sheng Lin, MD, PhD, Hung-Sheng Shang, MD, PhD, Chia-Cheng Lee, MD, Tom Chau, MD, PhD, and Shih-Hua Lin, MD

Contact Hours 1.00

CERP A 1.00

Expires Dec 26, 2027

Topics: ECG

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Hyperkalemia is a commonly encountered, life-threatening electrolyte emergency associated with high cardiovascular morbidity and mortality. Hyperkalemia occurs in between 1% and 10% of hospitalized patients and is more prevalent in patients with advanced chronic kidney disease or acute kidney injury in the intensive care unit (ICU). Incident hyperkalemia also is an independent predictor of mortality in patients with critical illness. Hyperkalemia can be detected by point-of-care (POC) blood testing and by artificial intelligence-enabled electrocardiography (ECG). These 2 methods of detecting hyperkalemia have not been compared. The aim of this study was to determine the accuracy of POC and ECG potassium measurements for central laboratory–validated hyperkalemia detection in patients with critical illness.

Objectives

  • Describe the error range of point-of-care device and artificial intelligence-enabled electrocardiography on potassium test.
  • Compare the accuracy between point-of-care device and artificial intelligence-enabled electrocardiography on hyperkalemia detection.
  • Demonstrate the different advantages between point-of-care device and artificial intelligence-enabled electrocardiography.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.